サーブ・バイオファーマ株式会社
Kagoshima, Japan
Active| Registration number | T4340001024984 |
|---|---|
| Type | Corporation |
| Registered name | サーブ・バイオファーマ株式会社 |
| Address | 鹿児島県鹿児島市桜ヶ丘８丁目３５‐１鹿児島大学大学院医歯学総合研究科内 桜ヶ丘8丁目35‐1鹿児島大学大学院医歯学総合研究科内, Kagoshima-shi, Kagoshima, JAPAN |
| Corporate number | 4340001024984 |
| Corporate number assigned on | 2022-08-24 |
| Invoice registered on | 2023-10-01 |
The invoice registration date is when the qualified-invoice-issuer registration (T-number) took effect — it is not the date the company was founded, and it resets only if the business re-registers after revocation or expiry.
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Reading (furigana) | サーブバイオファーマ |
| Reading (romaji) | Sabubaiofama |
| English name (unofficial) | Serve Bio Pharma K.K. |
| Postal code | 890-0075 |
Source: NTA Corporate Number Publication Site, refreshed daily.
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2025–2025; total ¥53.6M).
| 2025 FY2024 | 橋渡し研究プログラム ¥53.6M （文部科学省） 研究開発の実施 |
|---|
Contract details (excerpt): 浸潤・転移の難治性癌を制圧する革新的な免疫遺伝子搭載・腫瘍溶解性ウイルスの実用化への非臨床・臨床開発 ¥53.6M・随意契約（公募） · bidders 1
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
Doing due diligence on this supplier?
Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t4340001024984) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-21.
Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence